Published in Emerg Infect Dis on March 28, 2001
Genetic characterization and transmission cycles of Cryptosporidium species isolated from humans in New Zealand. Appl Environ Microbiol (2004) 1.21
Cryptosporidium parvum mixed genotypes detected by PCR-restriction fragment length polymorphism analysis. Appl Environ Microbiol (2002) 0.98
Molecular epidemiological analysis of Cryptosporidium isolates from humans and animals by using a heteroduplex mobility assay and nucleic acid sequencing based on a small double-stranded RNA element. J Clin Microbiol (2003) 0.82
Outbreak of Cryptosporidium hominis following river flooding in the city of Halle (Saale), Germany, August 2013. BMC Infect Dis (2015) 0.79
Genetic Diversity of Cryptosporidium in Children in an Urban Informal Settlement of Nairobi, Kenya. PLoS One (2015) 0.75
Changes in the levels of Cryspovirus during in vitro development of Cryptosporidium parvum. Parasitol Res (2015) 0.75
Genetic diversity within Cryptosporidium parvum and related Cryptosporidium species. Appl Environ Microbiol (1999) 4.22
Molecular characterization of Cryptosporidium isolates from humans and other animals using random amplified polymorphic DNA analysis. Am J Trop Med Hyg (1995) 3.21
Differentiating human from animal isolates of Cryptosporidium parvum. Emerg Infect Dis (1999) 2.89
Genotyping human and bovine isolates of Cryptosporidium parvum by polymerase chain reaction-restriction fragment length polymorphism analysis of a repetitive DNA sequence. FEMS Microbiol Lett (1996) 2.53
Genetic characterization of Cryptosporidium strains from 218 patients with diarrhea diagnosed as having sporadic cryptosporidiosis. J Clin Microbiol (1999) 2.36
An outbreak of cryptosporidiosis linked to a foodhandler. J Infect Dis (2000) 1.37
Virus-like, double-stranded RNAs in the parasitic protozoan Cryptosporidium parvum. Mol Microbiol (1997) 1.14
Outbreak of cryptosporidiosis associated with a water sprinkler fountain--Minnesota, 1997. MMWR Morb Mortal Wkly Rep (1998) 1.06
Presence of double-stranded RNAs in human and calf isolates of Cryptosporidium parvum. J Parasitol (2000) 0.98
Identification of 5 types of Cryptosporidium parasites in children in Lima, Peru. J Infect Dis (2000) 6.71
Phylogenetic analysis of Cryptosporidium parasites based on the small-subunit rRNA gene locus. Appl Environ Microbiol (1999) 5.57
Genetic diversity within Cryptosporidium parvum and related Cryptosporidium species. Appl Environ Microbiol (1999) 4.22
Genetic polymorphism among Cryptosporidium parvum isolates: evidence of two distinct human transmission cycles. Emerg Infect Dis (1997) 4.02
The evolution of primate malaria parasites based on the gene encoding cytochrome b from the linear mitochondrial genome. Proc Natl Acad Sci U S A (1998) 3.93
A low interleukin-10 tumor necrosis factor-alpha ratio is associated with malaria anemia in children residing in a holoendemic malaria region in western Kenya. J Infect Dis (1999) 3.26
Identification of species and sources of Cryptosporidium oocysts in storm waters with a small-subunit rRNA-based diagnostic and genotyping tool. Appl Environ Microbiol (2000) 2.91
Differentiating human from animal isolates of Cryptosporidium parvum. Emerg Infect Dis (1999) 2.89
Molecular characterization of cryptosporidium oocysts in samples of raw surface water and wastewater. Appl Environ Microbiol (2001) 2.58
Primary sequences of two small subunit ribosomal RNA genes from Plasmodium falciparum. Mol Biochem Parasitol (1988) 2.48
Identification of Plasmodium vivax-like human malaria parasite. Lancet (1993) 2.37
Genetic polymorphism and natural selection in the malaria parasite Plasmodium falciparum. Genetics (1998) 2.36
A longitudinal investigation of IgG and IgM antibody responses to the merozoite surface protein-1 19-kiloDalton domain of Plasmodium falciparum in pregnant women and infants: associations with febrile illness, parasitemia, and anemia. Am J Trop Med Hyg (1998) 2.33
Vivax malaria resistant to treatment and prophylaxis with chloroquine. Lancet (1993) 2.23
Variation in Cryptosporidium: towards a taxonomic revision of the genus. Int J Parasitol (1999) 2.07
Antigenic variation of a cysteine-rich protein in Giardia lamblia. J Exp Med (1988) 1.98
Polymorphism in the gene encoding the apical membrane antigen-1 (AMA-1) of Plasmodium falciparum. X. Asembo Bay Cohort Project. Mol Biochem Parasitol (2001) 1.96
Wild primate populations in emerging infectious disease research: the missing link? Emerg Infect Dis (1998) 1.91
Glycosylphosphatidylinositol anchors of Plasmodium falciparum: molecular characterization and naturally elicited antibody response that may provide immunity to malaria pathogenesis. J Exp Med (2000) 1.87
A comparison of Cryptosporidium subgenotypes from several geographic regions. J Eukaryot Microbiol (2001) 1.86
Degenerate cytotoxic T cell epitopes from P. falciparum restricted by multiple HLA-A and HLA-B supertype alleles. Immunity (1997) 1.84
Sequence variation in putative functional domains of the circumsporozoite protein of Plasmodium falciparum. Implications for vaccine development. J Biol Chem (1987) 1.82
Identification of T and B cell epitopes recognized by humans in the C-terminal 42-kDa domain of the Plasmodium falciparum merozoite surface protein (MSP)-1. J Immunol (1995) 1.79
Natural immune response to the C-terminal 19-kilodalton domain of Plasmodium falciparum merozoite surface protein 1. Infect Immun (1996) 1.78
Phylogenetic relationships of Cryptosporidium parasites based on the 70-kilodalton heat shock protein (HSP70) gene. Appl Environ Microbiol (2000) 1.76
Diarrheal deaths in the United States, 1979 through 1987. A special problem for the elderly. JAMA (1991) 1.69
Plasmodium falciparum genotypes, low complexity of infection, and resistance to subsequent malaria in participants in the Asembo Bay Cohort Project. Infect Immun (2001) 1.66
Cryptosporidium systematics and implications for public health. Parasitol Today (2000) 1.66
Sequence differences in the diagnostic target region of the oocyst wall protein gene of Cryptosporidium parasites. Appl Environ Microbiol (2000) 1.64
A population genetic study of the Cryptosporidium parvum human genotype parasites. J Eukaryot Microbiol (2001) 1.63
Differential effect and interaction of monocytes, hyperimmune sera, and immunoglobulin G on the growth of asexual stage Plasmodium falciparum parasites. Am J Trop Med Hyg (1999) 1.62
Phylogenetic relationship among the malaria parasites based on small subunit rRNA gene sequences: monophyletic nature of the human malaria parasite, Plasmodium falciparum. Mol Phylogenet Evol (1996) 1.56
Molecular and phylogenetic characterisation of Cryptosporidium from birds. Int J Parasitol (2001) 1.55
A geographic information system applied to a malaria field study in western Kenya. Am J Trop Med Hyg (1998) 1.53
Structure of the gene encoding the circumsporozoite protein of Plasmodium yoelii. A rodent model for examining antimalarial sporozoite vaccines. J Biol Chem (1987) 1.48
Species-specific 18S rRNA gene amplification for the detection of P. falciparum and P. vivax malaria parasites. Mol Cell Probes (1995) 1.46
Concurrent infections and HIV pathogenesis. AIDS (2000) 1.44
Sequence of the immunodominant epitope for the surface protein on sporozoites of Plasmodium vivax. Science (1985) 1.44
Giardia sp. cysts and infectious Cryptosporidium parvum oocysts in the feces of migratory Canada geese (Branta canadensis). Appl Environ Microbiol (1998) 1.43
Plasmodium falciparum antigen-induced human immunodeficiency virus type 1 replication is mediated through induction of tumor necrosis factor-alpha. J Infect Dis (1998) 1.42
Analysis of repeated hemoglobin measures in full-term, normal birth weight Kenyan children between birth and four years of age. III. The Asemobo Bay Cohort Project. Am J Trop Med Hyg (1999) 1.41
Predicted and observed alleles of Plasmodium falciparum merozoite surface protein-1 (MSP-1), a potential malaria vaccine antigen. Mol Biochem Parasitol (1998) 1.40
Polymerase chain reaction and a liquid-phase, nonisotopic hybridization for species-specific and sensitive detection of malaria infection. Am J Trop Med Hyg (1995) 1.39
Reinvestigation of the inhibition of actin polymerization by profilin. J Biol Chem (1985) 1.39
Evaluation of Cryptosporidium parvum genotyping techniques. Appl Environ Microbiol (1999) 1.38
An outbreak of cryptosporidiosis linked to a foodhandler. J Infect Dis (2000) 1.37
Cytokine profile suggesting that murine cerebral malaria is an encephalitis. Infect Immun (1997) 1.36
Prevalence of point mutations in the dihydrofolate reductase and dihydropteroate synthetase genes of Plasmodium falciparum isolates from India and Thailand: a molecular epidemiologic study. Trop Med Int Health (2000) 1.35
Longitudinal study of natural immune responses to the Plasmodium falciparum apical membrane antigen (AMA-1) in a holoendemic region of malaria in western Kenya: Asembo Bay Cohort Project VIII. Am J Trop Med Hyg (2001) 1.35
Immunity to placental malaria. I. Elevated production of interferon-gamma by placental blood mononuclear cells is associated with protection in an area with high transmission of malaria. J Infect Dis (1999) 1.32
Real-time PCR for the detection of Cryptosporidium parvum. J Microbiol Methods (2001) 1.32
The critical concentration of actin in the presence of ATP increases with the number concentration of filaments and approaches the critical concentration of actin.ADP. J Biol Chem (1984) 1.30
Presence of heterogeneous copies of the small subunit rRNA gene in Cryptosporidium parvum human and marsupial genotypes and Cryptosporidium felis. J Eukaryot Microbiol (1999) 1.30
Effect of Plasmodium falciparum parasitemia density on hemoglobin concentrations among full-term, normal birth weight children in western Kenya, IV. The Asembo Bay Cohort Project. Am J Trop Med Hyg (2000) 1.27
Detection of the Cryptosporidium parvum "human" genotype in a dugong (Dugong dugon). J Parasitol (2000) 1.21
Fcgamma receptor IIa (CD32) polymorphism is associated with protection of infants against high-density Plasmodium falciparum infection. VII. Asembo Bay Cohort Project. J Infect Dis (2001) 1.21
Genetic conservation of the Plasmodium falciparum apical membrane antigen-1 (AMA-1). Mol Biochem Parasitol (1997) 1.20
Genotyping Encephalitozoon cuniculi by multilocus analyses of genes with repetitive sequences. J Clin Microbiol (2001) 1.20
Immunogenicity and in vitro protective efficacy of a recombinant multistage Plasmodium falciparum candidate vaccine. Proc Natl Acad Sci U S A (1999) 1.19
Genetic diversity in the Block 2 region of the merozoite surface protein 1 (MSP-1) of Plasmodium falciparum: additional complexity and selection and convergence in fragment size polymorphism. Infect Genet Evol (2006) 1.19
Tumor necrosis factor-alpha promoter variant 2 (TNF2) is associated with pre-term delivery, infant mortality, and malaria morbidity in western Kenya: Asembo Bay Cohort Project IX. Genet Epidemiol (2001) 1.19
Nothing's simple about malnutrition: complexities raised by epidemic neuropathy in Cuba. Am J Clin Nutr (1996) 1.19
Diversity in the immunodominant determinants of the circumsporozoite protein of Plasmodium falciparum parasites from malaria-endemic regions of Papua New Guinea and Brazil. Am J Trop Med Hyg (1992) 1.18
Rate constants for actin polymerization in ATP determined using cross-linked actin trimers as nuclei. J Biol Chem (1984) 1.17
Lack of cross-reactivity between variant T cell determinants from malaria circumsporozoite protein. J Immunol (1988) 1.13
Species and strain-specific typing of Cryptosporidium parasites in clinical and environmental samples. Mem Inst Oswaldo Cruz (1999) 1.12
Preparation and polymerization of skeletal muscle ADP-actin. J Biol Chem (1984) 1.12
Phylogenetic analysis of Cryptosporidium isolates from captive reptiles using 18S rDNA sequence data and random amplified polymorphic DNA analysis. J Parasitol (1999) 1.12
Genotyping Encephalitozoon hellem isolates by analysis of the polar tube protein gene. J Clin Microbiol (2001) 1.12
Hospital control and multidrug-resistant pulmonary tuberculosis in female patients, Lima, Peru. Emerg Infect Dis (2001) 1.11
Wide distribution of the variant form of the human malaria parasite Plasmodium vivax. J Biol Chem (1991) 1.10
A study of polymorphism in the circumsporozoite protein of human malaria parasites. Am J Trop Med Hyg (1994) 1.10
Antibody responses to repetitive epitopes of the circumsporozoite protein, liver stage antigen-1, and merozoite surface protein-2 in infants residing in a Plasmodium falciparum-hyperendemic area of western Kenya. XIII. Asembo Bay Cohort Project. Am J Trop Med Hyg (2002) 1.09
All-cause mortality among young children in western Kenya. VI: the Asembo Bay Cohort Project. Am J Trop Med Hyg (2001) 1.08
Use of pyrosequencing to identify point mutations in domain V of 23S rRNA genes of linezolid-resistant Staphylococcus aureus and Staphylococcus epidermidis. Eur J Clin Microbiol Infect Dis (2007) 1.08
A redescription of Cryptosporidium galli Pavlasek, 1999 (Apicomplexa: Cryptosporidiidae) from birds. J Parasitol (2003) 1.06
Immunogenicity and epitope mapping of foreign sequences via genetically engineered filamentous phage. J Biol Chem (1988) 1.06
Cryptosporidium meleagridis in an Indian ring-necked parrot (Psittacula krameri). Aust Vet J (2000) 1.06
Sulfated polyanions inhibit invasion of erythrocytes by plasmodial merozoites and cytoadherence of endothelial cells to parasitized erythrocytes. Infect Immun (1996) 1.05
Antibodies anti bloodstream and circumsporozoite antigens (Plasmodium vivax and Plasmodium malariae/P. brasilianum) in areas of very low malaria endemicity in Brazil. Mem Inst Oswaldo Cruz (1998) 1.05
Biallelic polymorphism in the intron region of beta-tubulin gene of Cryptosporidium parasites. J Parasitol (1999) 1.04
Which genotypes/species of Cryptosporidium are humans susceptible to? J Eukaryot Microbiol (1999) 1.02
Point mutations in dihydrofolate reductase and dihydropteroate synthase genes of Plasmodium falciparum isolates from Venezuela. Am J Trop Med Hyg (1999) 1.02
Evolution of the immunodominant domain of the circumsporozoite protein gene from Plasmodium vivax. Implications for vaccines. J Biol Chem (1987) 1.01
Sequence variations in the non-repetitive regions of the liver stage-specific antigen-1 (LSA-1) of Plasmodium falciparum from field isolates. Mol Biochem Parasitol (1995) 1.01
Global occurrence of Plasmodium vivax-like human malaria parasite. J Infect Dis (1993) 1.01
Plasmodium falciparum: involvement of additional receptors in the cytoadherence of infected erythrocytes to microvascular endothelial cells. Exp Parasitol (1996) 1.01
Expression of proinflammatory cytokines in four regions of the brain in Macaque mulatta (rhesus) monkeys infected with Plasmodium coatneyi. Am J Trop Med Hyg (2000) 1.00
Epidemiology and strain variation of Cryptosporidium parvum. Contrib Microbiol (2000) 1.00
Analysis of binding of monoclonal antibody to a malarial peptide by surface plasmon resonance biosensor and integrated rate equations. J Immunol (1994) 1.00
Immunity to placental malaria. II. Placental antigen-specific cytokine responses are impaired in human immunodeficiency virus-infected women. J Infect Dis (2000) 1.00